Babies start building an immune system before they’re born, but it takes years to fully mature. The process begins in the womb, where a baby receives its mother’s antibodies through the placenta starting around 13 weeks of pregnancy. After birth, the immune system develops in stages, with the most significant growth happening during the first few years of life and functional maturity arriving somewhere around young adulthood.
Understanding this timeline helps explain why newborns are so vulnerable to infection, why the vaccination schedule starts early, and why breastfeeding offers real protective benefits.
Immune Protection Before Birth
A baby’s first immune protection comes directly from its mother. Starting around week 13 of pregnancy, a type of antibody called IgG begins crossing the placenta into the baby’s bloodstream. This transfer is slow at first. Between weeks 17 and 22, fetal antibody levels sit at only 5% to 10% of the mother’s levels. By weeks 28 to 32, the baby has about half of the mother’s concentration.
The real surge happens late in pregnancy. The largest amount of antibody transfers during the last four weeks, with a sharp increase after week 36. By full term, a baby’s antibody levels actually exceed the mother’s by 20% to 30%. This is why premature babies, especially those born before 28 weeks, face a significant immune disadvantage. They simply missed the window when most of that protective transfer occurs.
These borrowed antibodies give newborns temporary protection against many of the infections their mother has already fought off or been vaccinated against. But they don’t last. Maternal antibodies have a half-life of roughly 29 to 35 days, meaning they lose half their strength about every month. Most are gone within six to twelve months after birth, which creates a vulnerability gap just as the baby’s own immune system is still learning to function.
What Newborns Are Born With
Babies aren’t completely defenseless beyond their borrowed antibodies. They’re born with an innate immune system, the body’s first-response defense that reacts to threats in a general, non-specific way. This includes physical barriers like skin and mucous membranes, along with immune cells like neutrophils and monocytes that attack invaders without needing to “learn” them first.
However, these innate defenses work differently in newborns than in adults. Neutrophils and monocytes show lower activity and are present in smaller numbers compared to adult versions of the same cells. One notable exception: a group of cells called innate lymphoid cells are actually more active during infancy than at any other stage of life, suggesting they play a compensating role during this vulnerable period. Still, the overall picture is one of limited capacity, which is why newborns in their first 90 days are at heightened risk for serious infections from common pathogens, including respiratory viruses like RSV, rhinovirus, and influenza.
How Breast Milk Fills the Gap
Breastfeeding provides a form of ongoing immune support that picks up where placental transfer left off. The key player is a protective antibody called secretory IgA, which coats the lining of a baby’s gut, respiratory tract, and other mucosal surfaces. Unlike the antibodies transferred before birth, secretory IgA doesn’t enter the bloodstream. Instead, it works locally, preventing bacteria and viruses from penetrating the gut wall and entering the body.
Colostrum, the thick yellowish milk produced in the first few days after birth, is especially concentrated. It contains roughly 5.9 grams per liter of IgA, compared to about 3.7 grams per liter in mature breast milk. That early dose is particularly valuable because a newborn’s gut barrier is still immature and more permeable to potential pathogens.
The benefits go beyond simple germ-blocking. Secretory IgA in breast milk shapes which bacteria colonize the baby’s intestines, promoting beneficial species and suppressing harmful ones. It also helps the gut lining mature and develop stronger barrier function. Research published in the Proceedings of the National Academy of Sciences found that these effects persist well beyond the breastfeeding period, with early exposure to maternal antibodies influencing gut health and gene expression in intestinal cells into adulthood. When breastfeeding stops, the passive supply of secretory IgA drops off, leaving a temporary low point in gut immune protection until the baby’s own system catches up.
The Gut Microbiome as Immune Teacher
One of the most important things that happens in the first weeks of life has nothing to do with antibodies. During and immediately after birth, bacteria begin colonizing the baby’s intestines. The first arrivals are typically Enterobacteria and Staphylococcus species. Over the following weeks and months, the community diversifies dramatically, especially in babies who are breastfed or exposed to a variety of environments.
These early bacterial residents serve as a training program for the adaptive immune system. As gut bacteria interact with the intestinal lining, they trigger the development of regulatory T-cells, a type of immune cell that teaches the body to tolerate harmless substances (like food proteins and friendly bacteria) while still responding to genuine threats. This process produces anti-inflammatory signals that spread tolerance both locally in the gut and throughout the body. When this microbial training goes well, it helps calibrate the immune system properly. When it’s disrupted, through heavy antibiotic use in infancy, for example, the risk of allergic and autoimmune conditions appears to increase.
When Babies Start Making Their Own Antibodies
A baby’s adaptive immune system, the sophisticated branch that learns to recognize specific threats and remember them, begins functioning in a limited way shortly after birth. But it’s slow and inexperienced. Each time the body encounters a new pathogen, it takes days to weeks to mount an effective response, and the initial response is weaker than what an adult would produce.
Vaccines accelerate this learning process by introducing the immune system to weakened or inactivated versions of dangerous pathogens. After a single dose of certain live vaccines given at the recommended age, 90% to 95% of infants develop protective antibodies, typically within about 14 days. Varicella and mumps vaccines produce a slightly lower response, protecting 80% to 85% of recipients after one dose, which is why booster doses are part of the schedule.
The timing of the vaccine schedule reflects the interplay between waning maternal protection and developing infant immunity. By eight weeks of age, when many babies receive their first routine vaccinations, about a quarter of their initial maternal antibodies are still circulating. Starting vaccines at this point lets the baby begin building its own defenses before the borrowed ones disappear entirely, closing the vulnerability gap as much as possible.
How Long Full Maturity Takes
There’s no single birthday when a child’s immune system flips a switch to “fully developed.” Instead, it matures gradually throughout childhood. Infants and toddlers get sick frequently, often six to eight respiratory infections per year, not because something is wrong but because their immune system is encountering common viruses for the first time and building its memory library from scratch.
With each infection and each vaccine dose, the adaptive immune system adds to its repertoire. By school age, children have developed enough immune memory to fight off many common infections more quickly and with milder symptoms. The process continues through adolescence, with the immune system reaching its peak functional capacity in young adulthood. At that point, the combination of a fully developed innate system, a deep library of immune memory, and a well-calibrated inflammatory response means healthy young adults get sick less often and recover faster than at any other stage of life.
For practical purposes, the most vulnerable period is the first six months, when maternal antibodies are fading and the baby’s own immune system is still in its earliest stages of development. The first two years represent the steepest part of the learning curve, with rapid gains in immune function driven by natural exposures, vaccinations, and the ongoing maturation of the gut microbiome.